Cargando…
Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier
A proton-coupled organic cation (H(+)/OC) antiporter working at the blood–brain barrier (BBB) in humans and rodents is thought to be a promising candidate for the efficient delivery of cationic drugs to the brain. Therefore, it is important to identify the molecular entity that exhibits this activit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413594/ https://www.ncbi.nlm.nih.gov/pubmed/36015309 http://dx.doi.org/10.3390/pharmaceutics14081683 |
_version_ | 1784775788334153728 |
---|---|
author | Kurosawa, Toshiki Tega, Yuma Uchida, Yasuo Higuchi, Kei Tabata, Hidetsugu Sumiyoshi, Takaaki Kubo, Yoshiyuki Terasaki, Tetsuya Deguchi, Yoshiharu |
author_facet | Kurosawa, Toshiki Tega, Yuma Uchida, Yasuo Higuchi, Kei Tabata, Hidetsugu Sumiyoshi, Takaaki Kubo, Yoshiyuki Terasaki, Tetsuya Deguchi, Yoshiharu |
author_sort | Kurosawa, Toshiki |
collection | PubMed |
description | A proton-coupled organic cation (H(+)/OC) antiporter working at the blood–brain barrier (BBB) in humans and rodents is thought to be a promising candidate for the efficient delivery of cationic drugs to the brain. Therefore, it is important to identify the molecular entity that exhibits this activity. Here, for this purpose, we established the Proteomics-based Identification of transporter by Crosslinking substrate in Keyhole (PICK) method, which combines photo-affinity labeling with comprehensive proteomics analysis using SWATH-MS. Using preselected criteria, the PICK method generated sixteen candidate proteins. From these, knockdown screening in hCMEC/D3 cells, an in vitro BBB model, identified two proteins, TM7SF3 and LHFPL6, as candidates for the H(+)/OC antiporter. We synthesized a novel H(+)/OC antiporter substrate for functional analysis of TM7SF3 and LHFPL6 in hCMEC/D3 cells and HEK293 cells. The results suggested that both TM7SF3 and LHFPL6 are components of the H(+)/OC antiporter. |
format | Online Article Text |
id | pubmed-9413594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94135942022-08-27 Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier Kurosawa, Toshiki Tega, Yuma Uchida, Yasuo Higuchi, Kei Tabata, Hidetsugu Sumiyoshi, Takaaki Kubo, Yoshiyuki Terasaki, Tetsuya Deguchi, Yoshiharu Pharmaceutics Article A proton-coupled organic cation (H(+)/OC) antiporter working at the blood–brain barrier (BBB) in humans and rodents is thought to be a promising candidate for the efficient delivery of cationic drugs to the brain. Therefore, it is important to identify the molecular entity that exhibits this activity. Here, for this purpose, we established the Proteomics-based Identification of transporter by Crosslinking substrate in Keyhole (PICK) method, which combines photo-affinity labeling with comprehensive proteomics analysis using SWATH-MS. Using preselected criteria, the PICK method generated sixteen candidate proteins. From these, knockdown screening in hCMEC/D3 cells, an in vitro BBB model, identified two proteins, TM7SF3 and LHFPL6, as candidates for the H(+)/OC antiporter. We synthesized a novel H(+)/OC antiporter substrate for functional analysis of TM7SF3 and LHFPL6 in hCMEC/D3 cells and HEK293 cells. The results suggested that both TM7SF3 and LHFPL6 are components of the H(+)/OC antiporter. MDPI 2022-08-12 /pmc/articles/PMC9413594/ /pubmed/36015309 http://dx.doi.org/10.3390/pharmaceutics14081683 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kurosawa, Toshiki Tega, Yuma Uchida, Yasuo Higuchi, Kei Tabata, Hidetsugu Sumiyoshi, Takaaki Kubo, Yoshiyuki Terasaki, Tetsuya Deguchi, Yoshiharu Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier |
title | Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier |
title_full | Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier |
title_fullStr | Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier |
title_full_unstemmed | Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier |
title_short | Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier |
title_sort | proteomics-based transporter identification by the pick method: involvement of tm7sf3 and lhfpl6 in proton-coupled organic cation antiport at the blood–brain barrier |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413594/ https://www.ncbi.nlm.nih.gov/pubmed/36015309 http://dx.doi.org/10.3390/pharmaceutics14081683 |
work_keys_str_mv | AT kurosawatoshiki proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT tegayuma proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT uchidayasuo proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT higuchikei proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT tabatahidetsugu proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT sumiyoshitakaaki proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT kuboyoshiyuki proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT terasakitetsuya proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier AT deguchiyoshiharu proteomicsbasedtransporteridentificationbythepickmethodinvolvementoftm7sf3andlhfpl6inprotoncoupledorganiccationantiportatthebloodbrainbarrier |